TNYA Tenaya Therapeutics, Inc.

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

$2.90
As of 09/30/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/30/2021
Outstanding shares:  41,364,653
Average volume:  167,403
Market cap:   $124,507,606
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BNNXX52
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.48
PS ratio:   0.00
Return on equity:   -25.92%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy